(AMSG) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
June 18, 2013
(Stock Blog Hub,
12/23/12)
We have reiterated our Neutral recommendation on AmSurg Corporation (AMSG) with a target price of $31.00.
Even amid headwinds like reimbursement issues, higher expenses and...(read more)
(Stock Blog Hub,
9/26/11)
AmSurg Corp.'s (AMSG) second quarter EPS of $0.38 met the Zacks Consensus Estimate and the year-ago EPS. Economic uncertainty has been impacting AmSurg potential customers deferring...(read more)
(Benzinga,
10/22/10)
Hilliard Lyons is Neutral on AmSurg Corporation (NASDAQ: AMSG) in a research report released today.
In a note to clients, Hilliard Lyons writes, "There was little change in AmSurg's operating environment in the third quarter. As in...(read more)
Amsurg (AMSG) Company Overview
There is no analysis for AMSG yet. But you can go to Wikinvest to help create one!
What's in this AMSG analysis on Wikinvest...
- Company Overview
- Business and Financial Metrics
- Business Segments
- Gastroenterology
- Ophthalmology
- Orthopedics
- Key Trends, Risks, and Forces
- Caps on Medicare and Medicaid Reimbursements Limit Revenue Growth
- Technological Developments Allow More Procedures to be Performed in an Outpatient Setting
- Virtual Colonoscopy Decreases Demand for Conventional Colonoscopy Procedures
- Competition
- References
